Ginkgo Bioworks Investors

Ginkgo Bioworks is an innovative biotechnology company based in Boston, Massachusetts, founded in 2008 The company specializes in using advanced genetic engineering techniques to design custom microbes for various applications across diverse industries Ginkgo Bioworks has attracted significant investment, with funding exceeding $1 billion from various investors, including prominent venture capital firms and angel groups Its mission is to harness the power of biology to drive sustainable solutions and transform traditional manufacturing processes The company continues to expand its capabilities and partnerships to enhance its position as a leader in the synthetic biology sector


Investors

Founded Date: 2008
Last Funding Type: Post-IPO Equity
Headquarters: USA
Employee Number: 501-1000
Industry: FemTech
Estimated Revenue: $50M to $100M
Number Of Exists: 1
Funding Status: IPO
Investor Type: Angel Groups
Total Funding: 1573728100